Sanofi
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Sanofi's yearly results (2022–2025), compared with companies in France. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 15% in 3 years, but profit fell: €9 less profit per €100 of extra sales. Lower than 92% of companies in France.
- Tangible Assets Ratio: Of every €100 the company owns, €47 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 89% of companies in France.
- Cash Locked Ratio: For every €100 of sales, €26 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against €28 tied up three years earlier. More money tied up than 87% of companies in France.
Where €100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
€160Over the last 3 years, every €100 of reported profit came with €160 of operating cash.
Lower than 54% of companies in France.
Self-Funding Ratio
3.1×Over the last 3 years its own operating cash covered its investment spending (capex) 3.1 times.
Higher than 52% of companies in France.
Cash Locked Ratio
€26For every €100 of sales, €26 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against €28 tied up three years earlier.
More money tied up than 87% of companies in France.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 62% of companies in France.
Growth Efficiency Ratio
−€9Sales grew 15% in 3 years, but profit fell: €9 less profit per €100 of extra sales.
Lower than 92% of companies in France.
Asset Productivity Ratio
+15% / +0%In 3 years sales changed by +15% while total assets changed by +0%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
2.5×Debt due within a year is covered 2.5 times by its yearly operating cash.
Higher than 59% of companies in France.
Cash Cushion Ratio
−13%Debt, after subtracting cash, equals 13% of its market value (net debt).
Higher than 52% of companies in France.
Tangible Assets Ratio
47%Of every €100 the company owns, €47 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 89% of companies in France.
Tangible Net Worth Ratio
5%Of every €100 of net worth, €5 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 53% of companies in France.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Sanofi owes €0.46 for every €1 it owns. Net profit rose 41% in the year to Dec 2025, and shrank 2% a year on average over 3 years.
Compared with companies in France · latest annual results Dec 2025.
P/E ratio
23.1Investors pay €23.1 for every €1 of Sanofi's yearly profit, higher than 64% of companies in France.
P/B ratio
1.30The share price is 1.30 times Sanofi's book value per share, lower than 65% of companies in France.
Market cap
€89.8 BThe total market value of all of Sanofi's shares at today's price (share price × number of shares), larger than 74% of companies in France. PosiCap size class: Tito Cap.
Net worth (book value)
€69.2 BWhat Sanofi would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
€57.77Net worth divided by the number of shares. The share price of €74.95 is 1.3 times this, which is the P/B above.
Return on equity (ROE)
5.7%Sanofi earned 5.7% on its shareholders' money over the last year, lower than 92% of companies in France.
Owes vs Owns
0.46×Sanofi owes €0.46 for every €1 it owns (low), lower than 89% of companies in France.
Dividend yield
5.60%Sanofi pays 5.60% of its share price as dividends a year, higher than 80% of dividend-paying companies in France.
Revenue growth
+5%Revenue rose 5% in the year to Dec 2025, and grew 5% a year on average over 3 years.
Profit growth
+41%Net profit rose 41% in the year to Dec 2025, and shrank 2% a year on average over 3 years.
Profit margin
16.7%Sanofi keeps €17 of every €100 of revenue as net profit.
Cash quality
1.4×Cash from Sanofi's business was 1.4× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
15.3×Sanofi's operating profit covered its interest costs 15.3 times in the year to Dec 2025.
Cash vs debt
Net debtSanofi had €11.9 B more debt than cash (net debt) at Dec 2025.
Questions
What is Sanofi's P/E ratio?
Investors pay €23.1 for every €1 of Sanofi's yearly profit, higher than 64% of companies in France.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Sanofi: €89.8 B ÷ €69.2 B (30 Jun 2026) = 1.3.
What is Sanofi's return on equity?
Sanofi earned 5.7% on its shareholders' money over the last year, lower than 92% of companies in France.
How much does Sanofi owe compared with what it owns?
Sanofi owes €0.46 for every €1 it owns (low), lower than 89% of companies in France.
Does Sanofi pay a dividend?
Yes. Sanofi pays 5.60% of its share price as dividends a year, higher than 80% of dividend-paying companies in France.
Is Sanofi's revenue growing?
Revenue rose 5% in the year to Dec 2025, and grew 5% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.